NREP
NEW REPRESENTATIVE AT IB RECEIVED
21/08/2025
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
ST13
US500000079291322Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Descrição da marca
The mark consists of the stylized design of a curved band intertwined, above the stylized wording "HISTIDE", which is stacked above the stylized wording "RECODING THERAPEUTICS".
Titulares
Representantes
Jacqueline M. Lesser Ice Miller LLP
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Stem cells for scientific use; chemicals for biotechnological product development; proteins; chemicals for the purification of proteins for in-vitro use; synthetic peptides for the manufacture of cosmetics; stem cells other than for medical or veterinary use
Classe 3
Cosmetics; cosmetic products for skin appearance care; cosmetic preparations for skin regeneration; anti-aging skin care preparations; gels, lotions, serums, creams and ointments for cosmetic use; cosmetic preparations for hair restoration; hair lotions
Classe 5
Pharmaceutical products for tissue regeneration, for tissue repair, for tissue treatment, whether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseases, cartilaginous diseases, vascular diseases, neuronal degeneration, degeneration of tendons and ligaments, retinal degeneration, renal degeneration, degeneration of soft tissue, and diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants comprising living tissues; surgical dressings in the form of cloths ; surgical implants comprising living tissues grown from stem cells; synthesized peptides and polynucleotides (DNAs, RNAs) for pharmaceutical use for the treatment of tissue, whether relating to human or animal tissue, bone diseases, cartilaginous diseases, vascular diseases, neuronal degeneration, degeneration of tendons and ligaments, retinal degeneration, renal degeneration, degeneration of soft tissue, diseases with abnormal cell proliferation; nucleotide and amino acid preparations for medical use; biological tissue cultures for medical use
Classe 10
Surgical apparatus and instruments; prostheses, namely, orthopedic prostheses, artificial joints, jaw or facial prostheses, tendon and ligament prostheses, bone prostheses, artificial bone screws, dental prostheses, vascular prostheses, heart pacemakers, artificial heart valves, breast prostheses, penile prostheses; artificial implants, namely, artificial orthopedic implants, joints, jaw or facial implants, tendon and ligament implants, skin implants, bone implants, dental implants, vascular implants, breast implants, penile implants, nerve growth implants, intraocular implants; bone substitutes for surgical use; injectors for medical use, namely, medical fluid injectors; trocars
Classe 42
Technical consultancy in the field of scientific and industrial research; scientific, technological, industrial and quality control research and development of new products for others; scientific, technological, industrial and quality control research and development in the field of biotechnology; scientific, technological, industrial and quality control research and development for the pharmaceutical industry; scientific, technological, industrial and quality control research and development in the field of cosmetics; biological research services; chemical research services; scientific research services in the field of amino acids, proteins and cells; scientific laboratory services; chemistry services, namely, research and consulting in the field of chemistry; conducting clinical trials for others; technical project studies, namely, conducting scientific feasibility studies; engineering; chemical analysis; surveying
Classe 45
Intellectual property licensing; online social networking services
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
NEW REPRESENTATIVE AT IB RECEIVED
21/08/2025
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27/03/2023
TEAS CHANGE OF CORRESPONDENCE RECEIVED
27/03/2023
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
27/03/2023
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/03/2023
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/03/2023
TEAS CHANGE OF OWNER ADDRESS RECEIVED
27/03/2023
FINAL DECISION TRANSACTION PROCESSED BY IB
27/02/2022
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2022
FINAL DISPOSITION PROCESSED
02/02/2022
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/11/2021
REGISTERED-PRINCIPAL REGISTER
24/08/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2021
PUBLISHED FOR OPPOSITION
08/06/2021
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/05/2021
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2021
EXAMINER'S AMENDMENT ENTERED
03/05/2021
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/05/2021
EXAMINERS AMENDMENT E-MAILED
03/05/2021
EXAMINERS AMENDMENT -WRITTEN
03/05/2021
TEAS/EMAIL CORRESPONDENCE ENTERED
16/04/2021
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/04/2021
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/04/2021
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
15/04/2021
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/04/2021
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
15/04/2021
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
15/04/2021
TEAS CHANGE OF OWNER ADDRESS RECEIVED
15/04/2021
REFUSAL PROCESSED BY IB
08/11/2020
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
22/10/2020
REFUSAL PROCESSED BY MPU
22/10/2020
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/10/2020
NON-FINAL ACTION WRITTEN
01/10/2020
ASSIGNED TO EXAMINER
25/09/2020
NEW REPRESENTATIVE AT IB RECEIVED
11/09/2020
APPLICATION FILING RECEIPT MAILED
18/08/2020
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/08/2020
SN ASSIGNED FOR SECT 66A APPL FROM IB
13/08/2020
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.